tirzepatide for hashimoto's and Tirzepatide: Safety and Monitoring Guide tirzepatide and hashimoto's Hashimoto's and

Characteristics: Known for being selective, focusing on GH release rather than other hormones

10.1016/j.cmet.2016.04.006 202

[5] [6] Clinical trial data from the SURPASS and SURMOUNT studies demonstrate that gastrointestinal adverse eventsincluding nausea, diarrhea, vomiting, constipation, and abdominal discomfortoccur frequently with tirzepatide

Retatrutide is now in Phase 3 trials (the TRIUMPH program) for obesity, obesity with Type 2 diabetes, sleep apnea, and knee osteoarthritis

If patients are taking semaglutide and have a sudden loss of vision, they should stop taking the drug and see a doctor immediately

Portion control is particularly crucial